170 related articles for article (PubMed ID: 33053629)
21. Preparation and characterization of ZnO nanoparticles coated by chitosan-linoleic acid; fungal growth and biofilm assay.
Barad S; Roudbary M; Omran AN; Daryasari MP
Bratisl Lek Listy; 2017; 118(3):169-174. PubMed ID: 28319414
[TBL] [Abstract][Full Text] [Related]
22. Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis.
Jafri H; Ahmad I
J Mycol Med; 2020 Apr; 30(1):100911. PubMed ID: 32008964
[TBL] [Abstract][Full Text] [Related]
23. Antifungal Activity of Chitosan-Coated Poly(lactic-co-glycolic) Acid Nanoparticles Containing Amphotericin B.
Ludwig DB; de Camargo LEA; Khalil NM; Auler ME; Mainardes RM
Mycopathologia; 2018 Aug; 183(4):659-668. PubMed ID: 29497926
[TBL] [Abstract][Full Text] [Related]
24. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
Karabıçak N; Alem N
Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
[TBL] [Abstract][Full Text] [Related]
25. The effect of cetylpyridinium chloride (CPC) on the cell surface hydrophobicity and adherence of Candida albicans to human buccal epithelial cells in vitro.
Jones DS; Schep LJ; Shepherd MG
Pharm Res; 1995 Dec; 12(12):1896-900. PubMed ID: 8786963
[TBL] [Abstract][Full Text] [Related]
26. Activity of base analogues (5-fluorouracil, 5-flucytosine) against planktonic cells and mature biofilm of Candida yeast. Effect of combination with folinic acid.
Król J; Nawrot U; Bartoszewicz M
J Mycol Med; 2019 Jun; 29(2):147-153. PubMed ID: 31023592
[TBL] [Abstract][Full Text] [Related]
27. In vitro activity of Caspofungin combined with Fluconazole on mixed Candida albicans and Candida glabrata biofilm.
Pesee S; Angkananuwat C; Tancharoensukjit S; Muanmai S; Sirivan P; Bubphawas M; Tanarerkchai N
Med Mycol; 2016 May; 54(4):384-93. PubMed ID: 26768371
[TBL] [Abstract][Full Text] [Related]
28. [Comparison of two different methods for the investigation of in vitro susceptibilities of planktonic and biofilm forming Candida species to antifungal agents].
Kaynak Onurdağ F; Ozgen S; Abbasoğlu U; Gürcan IS
Mikrobiyol Bul; 2010 Oct; 44(4):619-31. PubMed ID: 21063974
[TBL] [Abstract][Full Text] [Related]
29. In vitro antifungal activity of silver nanoparticles against fluconazole-resistant Candida species.
Artunduaga Bonilla JJ; Paredes Guerrero DJ; Sánchez Suárez CI; Ortiz López CC; Torres Sáez RG
World J Microbiol Biotechnol; 2015 Nov; 31(11):1801-9. PubMed ID: 26335058
[TBL] [Abstract][Full Text] [Related]
30. Cetylpyridinium chloride and miramistin as antiseptic substances in chronic wound management - prospects and limitations.
Fromm-Dornieden C; Rembe JD; Schäfer N; Böhm J; Stuermer EK
J Med Microbiol; 2015 Apr; 64(Pt 4):407-414. PubMed ID: 25681322
[TBL] [Abstract][Full Text] [Related]
31. Comparative Study of the Effects of Fluconazole and Voriconazole on Candida glabrata, Candida parapsilosis and Candida rugosa Biofilms.
Madhavan P; Jamal F; Pei CP; Othman F; Karunanidhi A; Ng KP
Mycopathologia; 2018 Jun; 183(3):499-511. PubMed ID: 29380188
[TBL] [Abstract][Full Text] [Related]
32. Susceptibility of Candida biofilms to histatin 5 and fluconazole.
Konopka K; Dorocka-Bobkowska B; Gebremedhin S; Düzgüneş N
Antonie Van Leeuwenhoek; 2010 May; 97(4):413-7. PubMed ID: 20140514
[TBL] [Abstract][Full Text] [Related]
33. Excipient interaction with cetylpyridinium chloride activity in tablet based lozenges.
Richards RM; Xing JZ; Mackay KM
Pharm Res; 1996 Aug; 13(8):1258-64. PubMed ID: 8865323
[TBL] [Abstract][Full Text] [Related]
34. In vitro antifungal properties of mouthrinses containing antimicrobial agents.
Giuliana G; Pizzo G; Milici ME; Musotto GC; Giangreco R
J Periodontol; 1997 Aug; 68(8):729-33. PubMed ID: 9287062
[TBL] [Abstract][Full Text] [Related]
35. [Comparison of in vitro action of cetylpyridinium chloride containing preparations].
Deckers C; Ohgke H
Arzneimittelforschung; 1995 Dec; 45(12):1335-7. PubMed ID: 8595096
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of
Dentino AR; Lee D; Dentino K; Guentsch A; Tahriri M
Antibiotics (Basel); 2021 Apr; 10(4):. PubMed ID: 33924304
[TBL] [Abstract][Full Text] [Related]
37. Antifungal Activity of Commercial Essential Oils and Biocides against Candida Albicans.
Serra E; Hidalgo-Bastida LA; Verran J; Williams D; Malic S
Pathogens; 2018 Jan; 7(1):. PubMed ID: 29370147
[TBL] [Abstract][Full Text] [Related]
38. Biodegradable cross-linked chitosan nanoparticles improve anti-Candida and anti-biofilm activity of TistH, a peptide identified in the venom gland of the Tityus stigmurus scorpion.
Torres-Rêgo M; Gláucia-Silva F; Rocha Soares KS; de Souza LBFC; Damasceno IZ; Santos-Silva ED; Lacerda AF; Chaves GM; Silva-Júnior AAD; Fernandes-Pedrosa MF
Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109830. PubMed ID: 31349502
[TBL] [Abstract][Full Text] [Related]
39. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
40. Antifungal activity of silver nanoparticles in combination with nystatin and chlorhexidine digluconate against Candida albicans and Candida glabrata biofilms.
Monteiro DR; Silva S; Negri M; Gorup LF; de Camargo ER; Oliveira R; Barbosa DB; Henriques M
Mycoses; 2013 Nov; 56(6):672-80. PubMed ID: 23773119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
